Nom du produit:methyl 3-methyl-2,3-dihydro-1H-indole-4-carboxylate

IUPAC Name:methyl 3-methyl-2,3-dihydro-1H-indole-4-carboxylate

CAS:1715960-61-4
Formule moléculaire:C11H13NO2
Pureté:95%+
Numéro de catalogue:CM1075216
Poids moléculaire:191.23

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1715960-61-4
Formule moléculaire:C11H13NO2
Point de fusion:-
Code SMILES:COC(=O)C1=C2C(C)CNC2=CC=C1
Densité:
Numéro de catalogue:CM1075216
Poids moléculaire:191.23
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Indolines
Indoline is an aromatic heterocyclic organic compound with the chemical formula C8H9N. The compound is based on the indole structure, but the 2-3 bond is saturated. Indoles and their derivatives continue to inspire the development of synthetic organic chemistry even years after their discovery. The specific scaffold is a privileged structure and is ubiquitous in pharmaceuticals and biologically active compounds. Fused indolines as indole derivatives are of particular interest as they are often found in natural products and bioactives such as strychnine and tryptanthrins (alkaloids), mitosanes and mitosenes (antitumor activity) and isatisine (antiviral activity).

Column Infos

Bexicaserin
Longboard announced positive topline data from the PACIFIC Study evaluating bexicaserin (LP352), a potentially best-in-class and highly selective, oral, novel 5-HT2C receptor superagonist for seizures associated with a broad range of Developmental and Epileptic Encephalopathies (DEEs). The analysis showed that bexicaserin achieved a median seizure reduction of 53.3% in countable motor seizures across the DEE study population. Longboard will rapidly advance bexicaserin's global Phase 3 trial.